Cited by 179Inflammasome and immune disordersLiver Disease Diagnosis and TreatmentLiver physiology and pathology

The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.

Inflammasomes in Liver Fibrosis

Open access

Alegre, Fernando, Pelegrin, Pablo, Feldstein, Ariel·2017·Seminars in Liver Disease

Open this paper in CoChat — free account Open PDF

Abstract

Cell death and inflammation are two central elements in the development of liver fibrosis. Inflammasomes are intracellular multiprotein complexes expressed in both hepatocytes and nonparenchymal cells in the liver that are key regulators of inflammation and cell fate. They respond to cellular danger signals by activating caspase 1, releasing the proinflammatory cytokines IL-1β and IL-18, as well as initiating a novel pathway of programmed cell death termed “pyroptosis.” These processes can initiate and perpetuate an abnormal wound-healing response with the principle cellular target being the activation of hepatic stellate cells. From the various inflammasomes, the NLRP3 inflammasome has been increasingly implicated in the pathogenesis of chronic inflammatory liver diseases, including nonalcoholic steatohepatitis, a disease process that is soaring and has evolved as a primary cause of liver fibrosis and need for liver transplantation. In this review, the authors highlight the growing evidence for both indirect and direct effects of inflammasomes in triggering liver fibrosis as well as potential novel targets for antifibrotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1055/s-0037-1601350

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771

Show all 98 references

Research works printed but not linked: 3

Povero D, Panera N, Eguchi A, et al. Lipid-induced hepatocyte- derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. Cell Mol Gastroenterol Hepatol 2015;1(6):646-663.e4
Pelegrin PInflammasome activation by danger signals In: Couillin I, Petrilli V, Martinon F, eds. The Inflammasomes. Basel, Switzerland: Springer Basel; 2011:101-121
MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1beta by micro- vesicle shedding. Immunity 2001;15(5):825-835

Sorted by citations

Items 101–179 of 179

S-glutathionylation in hepatocytes is involved in arsenic-induced liver fibrosis through activation of the NLRP3 inflammasome, an effect alleviated by NAC
Li, Z., Li, H., Wang, D., Peng, X., Syed, B. M., & Liu, Q. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174534 · Cited by 17
Determination of selenium during pathogenesis of hepatic fibrosis employing hydride generation and inductively coupled plasma mass spectrometry
George, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0260 · Cited by 17
Inflammasome as an Effective Platform for Fibrosis Therapy
Chen, T., Xiao, F., Li, N., Shan, S., Qi, M., Wang, Z., Zhang, S., Wei, W., & Sun, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304180 · Cited by 17
Pentoxifylline mitigates cholestasis-related cholemic nephropathy
Ommati, M. M., Hojatnezhad, S., Abdoli, N., Manthari, R. K., Jia, Z., Najibi, A., Akbarizadeh, A. R., Sadeghian, I., Farshad, O., Azarpira, N., et al. (2021) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2021.111014 · Cited by 17
Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway
Zhang, Y.-Z., Yao, J., Zhang, L., Wang, C., Zhang, X., & Gao, B. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3044 · Cited by 16
Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
Köse-Vogel, N., Stengel, S., Gardey, E., Kirchberger-Tolstik, T., Reuken, P. A., Stallmach, A., & Bruns, T. (2019) · Cells · doi:10.3390/cells9010079 · Cited by 14
MicroRNA-7 attenuates secondary brain injury following experimental intracerebral hemorrhage via inhibition of NLRP3
Luo, B., Li, L., Song, X., Chen, H.-X., Yun, D., Wang, L., & Zhang, Y. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107670 · Cited by 15
Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
Seo, H.-Y., Lee, S. H., Park, J. Y., Han, E., Han, S., Hwang, J. S., Kim, M. K., & Jang, B. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290532 · Cited by 13
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 14
Sophocarpine attenuates septic liver injury through suppression of the NLRP3 inflammasome via autophagy‑mediated degradation
Hou, N., Dai, X., Lü, W., Yang, H., Yu, H., Liu, J., Li, H., Shuai, X., & Deng-bin, A. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9379 · Cited by 14
FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation
Hu, P., Sheng, M.-Y., Liu, Y.-P., & Zhang, C. (2022) · Human Cell · doi:10.1007/s13577-022-00760-y · Cited by 13
Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development
Sánchez, P. S., Rigual, M. D. M., & Djouder, N. (2021) · Cancers · doi:10.3390/cancers13205045 · Cited by 13
Application of single-cell RNA sequencing technology in liver diseases: a narrative review
He, L., Lu, A., Qin, L., Zhang, Q., Ling, H., Tan, D., & He, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4824 · Cited by 12
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
Zhao, Q., Wu, C., Fang, Y., Yu, Q., Wang, H., Fan, Y., & Wang, K. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.30424 · Cited by 12
Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Deficiency Attenuated Isoproterenol-Induced Cardiac Fibrosis via Reactive Oxygen Species/High Mobility Group Box 1 Protein Axis
Liu, C., Hu, T., Cai, Z., Xie, Q., Yuan, Y., Li, N., Xie, S., Yao, Q., Zhao, J., Wu, Q., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00713 · Cited by 12
Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433–3p/TLR10 axis
Su, S.-B., Lin, T., Liang, X., & Chen, W. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.11.002 · Cited by 13
[Retracted] Intervention Study of Dictyophora Polysaccharides on Arsenic‐Induced Liver Fibrosis in SD Rats
Wang, G., Zuo, P., Ding, K., Zeng, Q., Hu, T., Wei, S., & Luo, P. (2022) · BioMed Research International · doi:10.1155/2022/7509620 · Cited by 12
Retracted
A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease
Yin, J., Zhu, Y., Liu, R., Wang, W., Wang, Z., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599956 · Cited by 12
Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling Pathway
Wen, J., Wang, D., Wang, J., Wang, R., Wei, S., & Zhao, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5574010 · Cited by 11
Cranberry (Vacinium macrocarpon) phytochemicals inhibit hepatic stellate cell activation and liver fibrosis
Shi, L., Zhang, X., Liu, X., Jiang, Y., Deng, Y., & Liu, J. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101176 · Cited by 11
Hepatic Global Transcriptomic Profiles of Holstein Cows According to Parity Reveal Age-Related Changes in Early Lactation
Cheng, Z., Ferris, C. P., Crowe, M. A., Ingvartsen, K. L., Grelet, C., Vanlierde, A., Foldager, L., Becker, F. O., & Wathes, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129906 · Cited by 13
Dehydrotrametenolic acid methyl ester, a triterpenoid of Poria cocos, alleviates non-alcoholic steatohepatitis by suppressing NLRP3 inflammasome activation via targeting Caspase-1 in mice
Xia, L.-Y., Yu, N.-R., Huang, S., Qu, H. Y., Li, Q., Zhao, Q., & Leng, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01569-9 · Cited by 10
Capillin protects against non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation and oxidative stress
Li, B., Wang, R., Wang, L., Zhang, G., & Zhang, Y. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1984520 · Cited by 10
Immune cells and immune cell-targeted therapy in chronic pancreatitis
Zhang, Y., Zhang, W., Liu, X., Zhang, Q., Mao, T., & Li, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1151103 · Cited by 10
Anti‑inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats
Feng, S., Tong, H., Gao, J., Tang, S., Yang, W., Wang, G.-M., Zhou, H., & Wen, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10647 · Cited by 11
Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway
He, X.-Y., Xiong, X.-J., Liu, M., Liang, J., Liu, F., Xiao, J.-Y., & Wu, L. (2024) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-024-3801-x · Cited by 9
Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis
Fang, Z., Liu, C., Yu, X., Yang, K., Yu, T., Ji, Y., & Liu, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-72151-2 · Cited by 9
Inflammasomes as regulators of mechano-immunity
Bezbradica, J. S., & Bryant, C. E. (2023) · EMBO Reports · doi:10.1038/s44319-023-00008-2 · Cited by 9
Schistosoma antigens as activators of inflammasome pathway: from an unexpected stimulus to an intriguing role
Sanches, R. C. O., Souza, C. D. L. R., & Oliveira, S. C. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.08.001 · Cited by 9
Deciphering the enigma between low bioavailability and high anti-hepatic fibrosis efficacy of Yinchen Wuling powder based on drug metabolism and network pharmacology
Zhang, Y., Liu, T., Zhao, Y., Zhao, C., & Zhao, M. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117538 · Cited by 8
Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis
Ran, S., Song, L., Yang, H. S., Yu, J., Zhen, Y.-H., & Liu, Q. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301133 · Cited by 8
Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC‐TOF‐MS and UHPLC‐MS/MS
Qiao, M., Yang, J., Zhao, Y., Zhu, Y., Wang, X., Wang, X., & Hu, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8321732 · Cited by 8
Voluntary exposure to a toxin: the genetic influence on ethanol consumption
Hoffman, P. L., Saba, L. M., Vanderlinden, L. A., & Tabakoff, B. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9726-3 · Cited by 8
Mechanism of annexin A1/N-formylpeptide receptor regulation of macrophage function to inhibit hepatic stellate cell activation through Wnt/β-catenin pathway
Fan, J., Luo, N., Liu, G.-F., Xu, X., Li, S., & Lv, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3422 · Cited by 7
Identification of key genes involved in the alleviative effects of Polysaccharide of Atractylodes macrocephala Koidz on high-fat diet-induced nonalcoholic fatty liver disease in mice
Chen, X., Yang, S., Yu, H., Fu, X., Li, W., Li, B., Fu, C., Cao, X., Xu, D., & Cao, N. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106201 · Cited by 7
The function of necroptosis in liver cancer
Tayir, M., Wang, Y., Chu, T., Wang, X., Fan, Y.-Q., Cao, L., Chen, Y.-H., & Wu, D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167828 · Cited by 7
Gene polymorphisms of inflammatory factors in liver cirrhosis
Xiao, S., Pan, X., Huang, X., Liu, Y., Wen, S. W., & Liu, A. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1140427 · Cited by 6
Illuminating liver fibrosis: recent progress in the design and applications of highly sensitive fluorescent probes
Lv, Y., Ma, Z., Chong, Y., Wang, Z., Li, X., & Wang, F. (2025) · Materials Horizons · doi:10.1039/d5mh01447f · Cited by 5
TLR4-MyD88-NF-κB signaling pathway contributes to the progression of secondary hepatic injury and fibrosis in hepatolithiasis
Fang, Y., Zhou, L., Hu, X., Guo, J., Liao, J., & Zhang, Z. (2021) · European Journal of Inflammation · doi:10.1177/20587392211014762 · Cited by 5
The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro
Wang, S., Ye, F., Ren, Q., Sun, S., Xia, W., Wang, Z., Guo, H., Li, H., Zhang, S., Lowe, S., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117283 · Cited by 5
The pyroptosis and fibrotic diseases: a bibliometric analysis from 2010 to 2024
Zhu, L., Ou, L., Liu, B., Yang, Y., Su, C., Liu, O., & Feng, H. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02703-0 · Cited by 4
Nonalcoholic Fatty Liver Disease: A Wide Spectrum Disease
Rosso, N., & Bellentani, S. (2020) · Liver Diseases · doi:10.1007/978-3-030-24432-3_26 · Cited by 4
Knockdown of dual oxidase 1 suppresses activin A-induced fibrosis in cardiomyocytes via the reactive oxygen species-dependent pyroptotic pathway
Li, S., Li, Z., Yin, R., Nie, J., Fu, Y., & Ying, R. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105902 · Cited by 4
Auranofin attenuates Schistosoma mansoni egg-induced liver granuloma and fibrosis in mice
Atia, A. F., HUSSIEN, N. M. A., Sweed, D., Sweed, E. M., & Abokhalil, N. (2023) · Journal of Helminthology · doi:10.1017/s0022149x23000792 · Cited by 3
Flaxseed oil fraction reverses cardiac remodeling at a molecular level: improves cardiac function, decreases apoptosis, and suppresses miRNA-29b and miRNA 1 gene expression
Boshra, S. A., Nazeam, J. A., & Esmat, A. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04319-8 · Cited by 3
Unveiling the nexus: pyroptosis and its crucial implications in liver diseases
Miao, Z., Zhang, X., Xu, Y., Liu, Y., & Yang, Q. F. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05147-1 · Cited by 3
The Inflammatory and Fibrotic Patterns of Hepatic Stellate Cells Following Coagulation Factors (VII or X)-Shielded Adenovirus Infection
Shiri, A., Sarvari, J., Ghahestani, S. F., Gholijani, N., Tamaddon, A. M., Rastegari, M., Moattari, A., & Hosseini, S. Y. (2021) · Current Microbiology · doi:10.1007/s00284-020-02297-5 · Cited by 3
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
Li, Y., Quan, X., Tai, Y., Wu, Y.-T., Wei, B., & Wu, H. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i8.1156 · Cited by 2
A novel RELA K119 deacetylation mediated by SIRT7 is a pivotal activator to exacerbate liver inflammation and fibrosis in teleosts
Wu, X., Liang, X., Li, M., Liu, J., Ge, C., Xie, X., Wang, J., Zheng, Y., Wang, H., Wu, X., et al. (2025) · Marine Life Science & Technology · doi:10.1007/s42995-025-00287-9 · Cited by 2
ANACARDIUM OCCIDENTALE METHANOLIC NUT EXTRACT ATTENUATED TESTICULAR DYSFUNCTIONS IN HIGH-FAT DIET AND STREPTOZOTOCIN-INDUCED DIABETIC MALE WISTAR RATS
Ajao, F. O. (2023) · Journal of Applied Pharmaceutical Sciences and Research · doi:10.31069/japsr.v6i1.03 · Cited by 2
BTF3L4 Overexpression Mediates APAP-induced Liver Injury in Mouse and Cellular Models
Lin, J., Fan, A., Yifu, Z., Xie, Q., Liu, H., & Zhou, W. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00342 · Cited by 2
Inflammasome-induced inflammation and fibrosis in liver
Kaufmann, B. K., Kim, A. D., & Feldstein, A. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00017-7 · Cited by 2
Self-citation
Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
Qiao, G., Li, P., Wang, M., Li, C., Wang, Y., Xin, S., & Liu, H. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1092 · Cited by 2
Alantolactone mitigates thioacetamide-induced liver fibrosis in mice by inhibiting TLR4/MyD88/NF-κB axis
Almukadi, H. S., Alotaibi, N. N., Shaik, R. A., Abdel‐Naim, A. B., Esmat, A., & Eid, B. G. (2025) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_254_25 · Cited by 1
Liver-specific loss of Atg9a perturbs lipid metabolism and hepatocyte integrity
Mailler, É., Singh, A., Jarník, M., Li, Y., Holtzclaw, L. A., Hoffmann, V. J., Mine, S., Stallcup, P., Ordoubadinia, L., & Guardia, C. M. A. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2551028 · Cited by 1
IL-18 promotes pancreatic fibrosis via release of IL-4 from pancreatic stellate cells and induces macrophage M2 polarization
Tu, G., Peng, C., Xie, S., Zheng, S., Jiang, H., Chen, L., Yu, X., & Li, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-38168-5 · Cited by 1
Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application
Payushina, O. V., Tsomartova, D. A., Васильевна, Ч. Е., Ivanova, M. Y., & Kuznetsov, S. L. (2021) · Biology Bulletin Reviews · doi:10.1134/s2079086421010059 · Cited by 1
Immune infiltration analysis based on pyroptosis-related gene in metabolic dysfunction-associated fatty liver disease
Lian, X., & Tang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34348 · Cited by 1
Utility of T1 mapping and T2 mapping for non-invasive assessment of liver fibrosis: preclinical resultsPreprint
Rong, J., Zhu, Y., Zhu, K., Shao, M., Yin, X., Liu, T., & Wang, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.08.566354 · Cited by 1
Role of extracellular vesicles in hypoxia-induced hepatic injury in non-alcoholic fatty liver disease
Villanueva, A. H. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.180853744
Role of necroptosis in chronic hepatic inflammation and liver disease in Cu/Zn superoxide dismutase deficient micePreprint
Mohammed, S., Nicklas, E. H., Thadathil, N., Selvarani, R., Royce, G. H., Richardson, A. G., & Deepa, S. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.17.254888
Decision letter: Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon
(2021) · eLife · doi:10.7554/elife.73675.sa1
Collagen I is expressed by hepatocytes through activation AIM2/ASC/caspase-1 pathwayPreprint
Sheng, Q., He, Q., Situ, B., & Pan, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1732082/v1
Zhuyu Zhenggan Decoction Ameliorated Rat Liver Fibrosis via the Phosphoinositide 3 Kinase-Protein Kinase B Signaling Pathway Based on Network Pharmacology Analysis
Zhu, W. L., Ying, J. Y., & Qin, H. X. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.485
Collagen I is expressed by hepatocytes through activation of AIM2/ASC/caspase-1 signaling pathwayPreprint
Sheng, Q., Zhai, P., Chen, L., Zhou, L., Ou, X., Situ, B., Huang, J. S., & Pan, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2360883/v1
Liver fibrotic development is reduced through inflammation prevention by an adenosine derivative compound
Domı́nguez, M., de Vaca, R. P., Rodríguez‐Aguilera, J. R., Guerrero‐Celis, N., Velasco-Loyden, G., & de Sánchez, V. C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115216
The Role of Neutrophil Extracellular Traps (NETs) in Non-alcoholic Fatty Liver Disease (NAFLD): A Comprehensive Analysis of NETs-related GenesPreprint
Fang, Z., Yu, X., Liu, C., Yang, K., Ji, Y., & Liu, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3804984/v1
Additional file 2 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485719
Additional file 5 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485731
Additional file 3 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485725
Protopine attenuates hepatic fibrosis via HDAC6-mediated NLRP3 inflammasome activation
Li, Y., Liang, M., Wang, X., Zhu, Q., Nie, J., & Sun, L. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109394
Additional file 4 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485728
Additional file 1 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485716
Additional file 6 of The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Feng, Y., Li, W., Wang, Z., Zhang, R., Li, Y., Zang, L., Wang, P., Li, Z., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21485734
Additional file 1 of Flaxseed oil fraction reverses cardiac remodeling at a molecular level: improves cardiac function, decreases apoptosis, and suppresses miRNA-29b and miRNA 1 gene expression
Boshra, S. A., Nazeam, J. A., & Esmat, A. (2024) · Figshare · doi:10.6084/m9.figshare.24934229
Diversité des macrophages dans un modèle murin de stéatohépatite non alcoolique
Tran, S. (2019) · theses.fr (ABES) · doi:10.70675/22efc884z2788z43fazabc1zaeb115ea6833
Qijia Rougan Formula alleviates liver fibrosis by inhibiting NLRP3-mediated pyroptosis and regulating macrophage polarization
Ding, X., Li, B., HongFei, S. O. N. G., Liu, C., Zheng, Z., Liu, J., Li, W., & Feng, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1796042
Multiomics contributes to the discovery of common factors in alcohol- and hepatitis B virus-related liver fibrosis
Dong, Y., Guan, Q. Y., Zheng, B., Lv, G., Wang, X., & Jq, N. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004155
IL-18/IL-18R1 Involved in Pancreatic Fibrosis via Activating Pancreatic Stellate Cells
Aghamaliyev, U., Li, Z., Sirtl, S., Munker, S., Weniger, M., Yu, X., Levis, A., Brohawn, P. Z., Astanova, B., Tan, K., et al. (2026) · Digestive Diseases · doi:10.1159/ddi/acnag004

Authors: Alegre, F., Pelegrin, P., & Feldstein, A.
Affiliations: Universitat de València (ES)
Director, Biomedical Research Institute of Murcia (IMIB-Arrixaca), CIBERehd, Clinical University Hospital Virgen de la Arrixaca, Murcia, Spain
University of California San Diego (US)
Corresponding author: Feldstein, Ariel
ORCID: Alegre, Fernando
Feldstein, Ariel
Venue: Seminars in Liver Disease
Publisher: Georg Thieme Verlag KG
Published: 2017-05
Volume: 37
Issue: 02
Pages: 119-127
ISSN: 0272-8087 (ISSN-L)
1098-8971
DOI: 10.1055/s-0037-1601350
OpenAlex: W2619892599
Cited by: 176
References: 98
Citations by year: 2026: 4 · 2025: 12 · 2024: 19 · 2023: 21 · 2022: 31 · 2021: 26 · 2020: 35 · 2019: 18 · 2018: 6 · 2017: 4
FWCI: 1.61
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Seminars in Liver Disease (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism (U01AA022489)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082451)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: inflammasome, liver fibrosis, NLRP3 inflammasome, caspase-1, IL-1β, IL-18, pyroptosis, hepatic stellate cells, nonalcoholic steatohepatitis, chronic liver inflammation, antifibrotic therapy, wound healing
MeSH terms: Alarmins, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Anti-Inflammatory Agents, Humans, Liver Cirrhosis, Signal Transduction, Inflammation Mediators, Receptors, Pattern Recognition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammasomes in Liver Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks